Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AB-101 |
Synonyms | |
Therapy Description |
AB-101 are umbilical cord blood-derived NK cells expressing a high-affinity CD16 variant, which may lead to antibody-dependent cellular cytotoxicity and increased anti-tumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AB-101 | AB101|AB 101 | AB-101 are umbilical cord blood-derived NK cells expressing a high-affinity CD16 variant, which may lead to antibody-dependent cellular cytotoxicity and increased anti-tumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|